Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit
Semaglutide is the active ingredient in Danish major Novo Nordisk’s blockbuster diabetes and weight loss drugs Wegovy and Ozempic
What's Your Reaction?
